AzTrials
AzTrials

Diet-induced ThermogenesisCreaBATNCT04086381

Creatine Effect on Brown Adipose Tissue Activation

A study testing Creatine monohydrate in people with Diet-induced Thermogenesis and Brown Adipose Tissue Activation, run by Maastricht University at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Pre-clinical studies indicate that creatine may play a substantial role in diet-induced thermogenesis and may have a profound effect on energy balance. A recent retrospective study of BAT activation on PET-CT scans in humans showed a positive association with the estimated renal creatinine clearance and BAT… Read more about this study

Who is it for?
Ages 18 to 30 yearsHealthy volunteers can take part
What is being tested?
Creatine monohydrate
Type of treatment
Pill or oral medicine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
14 participants
Where
1 siteNetherlands
Study dates
1 May 2018to 22 Jan 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Male or female;
  • 18 to 30 years of age;
  • Consuming a vegetarian diet;
  • BMI 20-25 kg/m2.

Who cannot join

  • Not meeting all inclusion criteria;
  • Non-vegetarian diet;
  • Excessive alcohol and/or drug abuse;
  • Significant allergies or intolerances concerning the study products;
  • Participation in another biomedical study within 1 month before the first study visit, possibly interfering with the study results;
  • Medication use known to hamper subject's safety during the study procedures;
Show all 12Show fewer
  • Subjects with contra-indications for MRI and/or PET-CT;
  • Subjects who do not want to be informed about unexpected medical findings;
  • Subjects who do not want that their treating physician to be informed;
  • Co-morbidities to which the intervention or program that may pose as a complicating factor;
  • Inability to participate and/or complete the required measurements;
  • PET-CT scan in the last 12 months.

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Maastricht University

    Maastricht, Limburg, 6229ER

Other trials in Netherlands

About this study

Official title: Creatine Monohydrate Supplementation in Young, Healthy Vegetarian Adults and Its Effect on Brown Adipose Tissue Activation

Pre-clinical studies indicate that creatine may play a substantial role in diet-induced thermogenesis and may have a profound effect on energy balance. A recent retrospective study of BAT activation on PET-CT scans in humans showed a positive association with the estimated renal creatinine clearance and BAT activation, possibly linking creatine metabolism in humans to BAT activity. In humans, so far little options are available to activate brown adipose tissue. The most potent intervention to activate BAT is via cold, which has previously been shown to have metabolic effects in humans. Provided the potential health benefits of brown adipose tissue activation in humans, and provided the role of brown fat in diet induced thermogenesis, we here aim to determine whether creatine monohydrate supplementation can increase diet-induced thermogenesis and activate brown adipose tissue in humans.

Being tested
Creatine monohydrate, placebo cellulose
Keywords
Brown adipose tissue, Creatine monohydrate, Diet-induced thermogenesis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Creatine monohydrateDietary supplement

    5 grams of creatine monohydrate, four times daily, for 9 consecutive days.

  • placebo celluloseDietary supplement

    oral ingestion of placebo containing 20 gram cellulose daily

Study groups in NCT04086381
Study groupRoleWhat they receive
InterventionActive comparatorOral injestion of 20 grams of creatine monohydrate daily
Receives: Dietary Supplement: Creatine monohydrate
PlaceboPlacebo comparatorOral injestion of 20 grams of cellulose daily
Receives: Dietary Supplement: placebo cellulose

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Brown adipose tissue activation through 18F-FDG PET-MRI

    Standard Uptake Value (SUV)

    Measured: Day 10 of protocol

Secondary outcomes (2)
  1. Diet-induced thermogenesis through indirect calorimetry

    Whole body energy expenditure in kJ/kg/min

    Measured: Day 8 of protocol

  2. Posphocreatine (PCr) Recovery through 31P-MRS

    Halftime of PCr Recovery

    Measured: Day 9 of protocol

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Sep 2019
  2. Study start1 May 2018
  3. Primary completion22 Jan 2020
  4. Study completion22 Jan 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Model description
A double-blind, randomised, controlled, cross-over intervention trial.
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
14 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04086381
Sponsor's protocol ID
NL64709.068.18
Acronym
CreaBAT
Status last verified
Feb 2021
First submitted
10 Sep 2019
Last updated
24 Feb 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Connell NJ, Doligkeit D, Andriessen C, Kornips-Moonen E, Bruls YMH, Schrauwen-Hinderling VB, van de Weijer T, van Marken-Lichtenbelt WD, Havekes B, Kazak L, Spiegelman BM, Hoeks J, Schrauwen P. No evidence for brown adipose tissue activation after creatine supplementation in adult vegetarians. Nat Metab. 2021 Jan;3(1):107-117. doi: 10.1038/s42255-020-00332-0. Epub 2021 Jan 18.

    PubMed 33462512

Questions about this trial

What is this clinical trial studying?

A study testing Creatine monohydrate in people with Diet-induced Thermogenesis and Brown Adipose Tissue Activation, run by Maastricht University at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Brown adipose tissue activation through 18F-FDG PET-MRI (time frame: Day 10 of protocol). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04086381, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in